Novotná M, Huvar I, Bláha O
Gynekologicko-porodnické oddĕlení Nemocnice Milosrdných bratrí, Brno.
Ceska Gynekol. 2002 Sep;67(5):297-304.
To assess relationship of long-term use of combined oral contraception (COC) and women health, discussion about myths connected with use of COC.
Review of literature.
Department of Obstetrics and Gynaecology, Hospital of Merciful Brothers, Brno, Czech Republic.
Identification of studies able to address the topic using Medline database search.
Besides reliable control of fertility COC protect women against dysmenorrhea, iron deficiency anemia, ovarian cysts and uterine fibroids. COC plays very important role in gynecologic endocrinology suppressing effectively hyperandrogenism, which has not only cosmetic effect but brings also improvement in cardiovascular health of affected perimenopausal women. Premenopausal using of COC could help preserve bone mineral density and can reduce the risk of developing Alzheimer's disease. The most important feature is protective effect against endometrial (by 70%) and ovarian (by 50%) cancer which increases with duration of COC use and is long lasting and may be observed 15 to 20 years after stopping use. Association of use COC with increased risk neither of cervical cancer nor breast cancer has not been confirmed. Controversy still persists over the association of long-term (longer than 8 years) COC use by young nulliparas and breast cancer. The risk in this group of users is probably slightly increased. But no authorities recommended any restriction of COC's prescription. Some studies have suggested an inverse relationship between use of COC and risk of colorectal cancer. The only established evidence of direct association between OC use and cancer risk is the increased risk for hepatocellular carcinoma in the absence of hepatitis B (but maximum by 4 cases per 1,000,000 users per year).
Most non-contraceptive health benefits of COC are still not widely appreciated in spite of much evidence. The final decision of contraception method is upon well and adequate informed user by well educated doctor.
评估复方口服避孕药(COC)的长期使用与女性健康的关系,探讨与COC使用相关的误解。
文献综述。
捷克布尔诺仁慈兄弟医院妇产科。
通过Medline数据库搜索确定能够解决该主题的研究。
除了可靠地控制生育外,COC还能保护女性免受痛经、缺铁性贫血、卵巢囊肿和子宫肌瘤的困扰。COC在妇科内分泌学中起着非常重要的作用,能有效抑制高雄激素血症,这不仅具有美容效果,还能改善受影响的围绝经期女性的心血管健康。绝经前使用COC有助于保持骨密度,并可降低患阿尔茨海默病的风险。最重要的特点是对子宫内膜癌(降低70%)和卵巢癌(降低50%)具有保护作用,这种保护作用随着COC使用时间的延长而增加,且持续时间长,在停药后15至20年仍可观察到。使用COC与宫颈癌和乳腺癌风险增加之间的关联尚未得到证实。对于年轻未生育女性长期(超过8年)使用COC与乳腺癌之间的关联仍存在争议。该组使用者的风险可能略有增加。但没有权威机构建议对COC的处方进行任何限制。一些研究表明COC的使用与结直肠癌风险之间存在负相关。OC使用与癌症风险之间唯一确定的直接关联证据是在没有乙型肝炎的情况下肝细胞癌风险增加(但每年每100万使用者最多增加4例)。
尽管有大量证据,但COC的大多数非避孕健康益处仍未得到广泛认可。避孕方法的最终决定应由受过良好教育的医生充分告知使用者后做出。